McKesson Ventures
  • Portfolio
  • News
  • Team
  • About Us
    • Our Approach
    • About McKesson
    • Contact Us

Prudentia Sciences Announces Series A Led by McKesson Ventures, Accelerating Due Diligence for Life Sciences Dealmaking

by McKesson Ventures | Jan 7, 2026 | Press Releases

Biotechnology research and life sciences dealmaking company Prudentia Sciences recently announced that it has secured $20 million in Series A financing, led by McKesson Ventures with participation from SignalFire. This newest investment brings Prudentia’s total...

Recent Posts

  • Silver and LYNX Launch Production AI Claims Automation to Help TPAs Modernize Claims Processing
  • HarmonyCares Ranks Among Medicare’s Top ACO REACH Performers for 2024
  • UNC Health Scales Medication Access By Over 45% Without Adding Headcount Using Latent Health’s Pharmacy Intelligence Platform
  • Reimagine Care Expands AI-Enabled Virtual Oncology Model with Moffitt Cancer Center Following Strong Patient and Clinical Outcomes
  • Atropos Health and Guidehouse Launch Point-of-Care Clinical Decision Support Solution for Life Sciences
McKesson Ventures

One Post Street, 21st Floor
San Francisco, CA 94104

IN THE NEWS

ABOUT US

CONTACT US

  • Follow
©2026 McKesson Ventures | Privacy Notice | Disclaimer | Cookie Settings
McKesson Ventures

One Post Street, 21st Floor
San Francisco, CA 94104

©2026 McKesson Ventures | Privacy Notice | Disclaimer | Cookie Settings